28 Views
Imagine your doctor detects a health issue before you even feel the first symptom. Your pacemaker sends an alert directly to your cardiologist. A glucose monitor communicates your glucose levels to your smartphone. A smartwatch subtly flags abnormal heart rates while you are asleep. This isn’t a glimpse of the distant future, it’s the Internet of Medical Things (IoMT) at work.
The Internet of Medical Things market is a rapidly emerging network of connected smart medical devices that are linked to the internet and are gathering and sharing vital health data and information constantly. Closely tied to healthcare software trends, this new technology is transforming care delivery, improving outcomes, saving time, and even saving lives.
The IoMT market is estimated to grow from USD 230.69 billion in 2024 to USD 658.57 billion by 2030, with a strong CAGR of 18.2%. The growth is expected to be around the 2025-2030 period, through the widespread acceptance of real-time AI diagnostics, monitoring, and cloud-based solutions. That period will change how diagnosis is done, recovery happens, and how we run healthcare operations, and lead to a connected healthcare revolution already underway.
The Internet of Medical Things (IoMT) is a network of connected medical devices that collect, transmit, and sometimes analyze health data over the internet. This ecosystem includes:
IoMT is situated as the backbone in the healthcare digital transformation by changing passive devices into active use, the IoMT enables true real time monitoring and decreases unnecessary hospital visits enabling early intervention and diagnoses.
Everyday examples of IoMT being utilized could include a smartwatch detecting irregular heart rhythms, a connected inhaler tracking asthma medication usage, or sensors located in the hospital monitoring equipment. All of the above are examples of how IoMT is quickly growing as a market and becoming an active participant in healthcare systems across the world.
The Internet of Medical Things market is poised to grow in leaps and bounds from 2025 to 2030, due to advancements in technology, healthcare requirements, and governmental policies. Healthcare systems are increasingly relying upon integrated healthcare systems, including telehealth and AI-infused diagnostics.
Virtual care is integrated into modern healthcare delivery. The global telemedicine market was valued at USD 104.64 billion in 2024 and will reach USD 334.80 billion by 2032, with a CAGR of 16.9%. The rise of telehealth is increasing the demand for IoMT solutions that can automatically collect, store, transmit and act on patient data for remote consultations and diagnostics.
Chronic diseases, such as diabetes, cardiovascular disease and chronic obstructive pulmonary disease (COPD) continue to rise. According to WHO, non-communicable diseases contribute to approximately 41 million deaths annually, which equates to roughly 74% of deaths globally, with the majority in poorer countries.
IoMT systems not only reduce the need for in-hospital care for these patients but also allow continued monitoring, keep the rate of hospital readmissions to a minimum, and support proactive care for their respective illnesses.
Emerging technologies are enhancing the capabilities of IoMT. AI is predicting risks and offering diagnostics.
According to McKinsey, generative AI could add between USD 60 to 110 billion per year to the pharmaceutical and medical products industry.
Policies are enabling a quicker adoption of IoMT. In the US, the FDA’s Digital Health Innovation Action Plan eases the approval processes for IoMT devices. Similar plans are being developed in Europe and Asia to bolster regulatory and compliance infrastructure.
The focus of healthcare is evolving toward the precision and personalization of data. The Internet of Medical Things, IoMT, makes available dynamic 24/7 real-time health data. Physicians can make timely adjustments to treatment and proactively intervene to enhance patient outcomes.
The Internet of Medical Things market is now serving hospitals, medical centres, and homes after evolving from piloting to full-fledged programs. Due to a decade of digitization in the healthcare sector, IoMT is now deeply embedded into the system healthcare infrastructure of the sector alongside the evolving expectations of the customers.
The IoMT market is projected to grow from 97.73 billion in 2025 to 244.4 billion by 2029, with a CAGR of 25.8%, as stated by Research and Markets.
The following market segmentation can be done:
The remote patient monitoring segment is growing the fastest due to the aged population and the growing acceptance of care-at-home models.
The healthcare infrastructure in North America is much more advanced, with a long history of technology adoption, and it makes a large number of investments in health tech, making it the dominant market. North America accounted for 36.1% of global IoMT revenue in 2023, driven primarily by U.S. sales.
Europe follows, led by Germany, the U.K., and France, where connected technologies are being used to enhance the management of chronic diseases in public health systems.
In China, India, Japan, and South Korea, as well as in rural or underserved regions, the population size, government-sponsored digital health initiatives, and mobile technology adoption are making the Asia-Pacific region the fastest growing market.
The following tech and healthcare companies are set to influence the global IoMT projection of 2025.
Current Health, Tytocare, and Biofourmis are other startups with AI-enabled remote monitoring systems and integrated software, hardware, and clinical workflows. Startups are likely to be the most agile and innovative, and thus the primary accelerators for the next wave of IoMT expansion.
The IoMT market is advancing significantly, but there are constant and critical issues when it comes to data security. With millions of medical and IoT devices being used in the medical field to aid in transmitting critical health data, the chances of hacking, data breaches and data misuse are always an issue.
In 2024, healthcare had the highest average data breach cost of any industry — USD 10.93 million per incident. Although slightly lower than in 2023, it remains the most expensive sector to secure.
Regulatory response is strengthening worldwide:
However, technology moves faster than regulation. Even with robust frameworks, healthcare organizations must balance rapid IoMT adoption with secure, compliant, and ethical practices to maintain patient trust in 2025 and beyond.
The Internet of Medical Things market will experience a significant transformation between 2025 and 2030. New technologies and business models will contribute to developing connected healthcare delivery that is instant, smart, and personalized.
The role of artificial intelligence in IoMT innovation is expanding. Devices are evolving from passive monitors to real-time analytical data-fuelled tools that scan patient data for anomalies, forecast risks, and allow for timely intervention.
The growing number of IoMT devices which capture sensitive health data increases the issues of data security, privacy, and interoperability. Blockchain technology’s decentralized ledger that logs every access and alterations to data provides a solution. It guarantees transparency which lowers fraud and streamlines data exchange between networks.
The integration of Internet of Medical Things (IoMT) platforms is expected to increase the value of the global blockchain in the healthcare market from USD 531 million in 2021 to USD 16.3 billion by 2031 at a CAGR of 40.8%.
Services that are time-critical such as real-time ventilator monitoring or emergency alerts cannot depend solely on the cloud for processing. Edge computing processes data nearer to the device, which improves reliability in data-sensitive shifts like IoMT devices.
Gartner predicts that 75% of the data created by an enterprise will originate outside of data centers or the cloud by the year 2025, up from just 10% in 2018. This promotes improved patient safety as it has led to acceleration of data supported insights.
The latest generation of wearables lets non-invasive devices such as smart patches, skin-embedded electronics, and glucose monitors nonsurgically provide ongoing chronic care, elder monitoring, and preventive health. These devices provide astonishing capabilities tracking hydration, stress, blood oxygen levels, and metabolic state, allowing additional non-invasive health monitoring options.
According to IDC, the wearable space is expected to ship just over 537 million devices in 2024, and 6.1% growth in 2025.
Healthcare providers are increasingly turning to healthcare software providers that offer subscription-based IoMT services. Under IoMT-as-a-Service (IoMTaaS), hospitals and clinics receive connected devices, patient data management software, and remote clinician support in a monthly package—avoiding large upfront costs.
Healthcare software companies and digital health startups are making improvements to IoMTaaS and existing software along with data and care coordination. This is appealing to both urban hospitals and rural health care networks.
The next five years will be pivotal for the Internet of Medical Things market. Adoption has already occurred, and growth is anticipated to accelerate even more as IoMT is fully adopted in healthcare systems and patient care is normalized.
The IoMT market will be valued at USD 56.07 billion in 2025, and projected to reach USD 125.49 billion by 2030, with a CAGR of 17.48%. The growth spike was ignited by increased demand for remote monitoring solutions, connected care, and more personalized health.
Significantly, this outpaces the growth rate of a number of other segments in digital health, illustrating IoMT’s advancement as the “central nervous system” of modern healthcare, facilitating everything from early diagnostics to post-treatment follow-ups.
As with other channels, large hospitals and health systems are still IoMT’s leading users, applying it to inpatient monitoring, asset tracking, and surgical robotics. Outpatient clinics are beginning to employ portable, AI-enhanced devices to expedite and stimulate engagement in diagnostics. The surge in remote monitoring also drives growth in home healthcare services.
Currently, almost 64 percent of patients with IoMT access utilize at least one device, and the use of IoMT-enabled biosensor wearables is actively transforming the bi-directional workflows of care.
The following developments are anticipated to enhance IoMT capabilities by 2030:
IoMT is forecast to undergo rapid growth and evolve into the primary infrastructure for healthcare delivery systems across the world, thanks to advanced software systems, more precise hardware and quicker connectivity.
The rapid advancement of technologies related to the Internet of Medical Things (IoMT) comes with critical challenges that must be addressed in order to ensure sustainable and global adoption.
Recent research suggests that the cost of data breach of healthcare institutions is currently around USD 9.77 million, well over the global average of USD 4.88 million. This, combined with the sensitive nature of health data, makes the IoMT sector a target for cyberattacks. This clearly indicates that IoMT technologies require much stronger cybersecurity, better encryption, and advanced industry-specific regulations.
Due to a large number of IoMT devices functioning on proprietary systems, integrating them with other clinical software systems is problematic. This, in turn, results in a data silo, which hinders the effectiveness of real-time analytics and slows coordinated, cross-disciplinary care.
Lower levels of digital literacy in developing countries combine with poor internet access and weak IT infrastructure to hinder IoMT adoption. Without targeted investment, IoMT adoption in these regions is slowing down while the rest of the world continues to advance in the Internet of Medical Things technologies.
The nature of surveillance and remote monitoring of medical devices raises important issues regarding privacy of the patient’s data, monitoring and patient consent. Since the compliance and ethical boundaries are shifting as technologies advance there’s a great uncertainty for the healthcare providers.
The next growth phase of the Internet of Medical Things market will depend on how different stakeholders act on emerging opportunities:
Providers can streamline clinical decision-making and improve patient outcomes via proactive patient monitoring and remote care. These advancements reduce hospital readmissions, report care quality improvements, and reduce operational costs.
There exists an opportunity to build IoMT systems that are compliant and scalable, interlacing with healthcare technology systems seamlessly. There are also unmet needs for AI analytics, device interoperability, as well as IoMT cloud-native solutions that can scale securely.
Governments can foster adoption with clear policies, investments in health infrastructure, and other financial incentives, as seen with the FDA’s Digital Health Innovation Action Plan and Europe’s AI Act, both of which affect policy for connected healthcare.
The emphasis should now be on late-stage areas such as IoMTaaS, at-home testing kits, and AI diagnostics. Global venture funding reached $314 billion in 2024, growing by 3% from 2023. This surge indicates a positive outlook from investors on the innovation within health technology.
The Internet of Medical Things (IoMT) is a growing part of the healthcare world as evidenced by its implementation across hospitals, clinics, and home settings.
Cleveland Clinic automates the remote care of patients with heart failure using IoMT devices, a virtual command center, and its hospital-at-home program. In the Journal of the American College of Cardiology: Heart Failure, one study reported a 30-day readmission rate of 12.4% versus 16.9% for patients receiving traditional hospital care.
As a result of the implementation of smart sensors and connected devices in the ICU, Apollo Hospitals improved equipment uptime and emergency response, and real-time patient monitoring of vital signs across multiple facilities became possible.
With the Tytocare connected and portable medical kit, patients can perform heart, lung, and throat examinations remotely. Data is uploaded to telehealth platforms for analysis by physicians. This remote access is especially beneficial to patients living in rural America or European regions.
Philips’s cloud-based IoMT system integrates data from wearables, connected gadgets, and even Electronic Health Records (EHRs) for proactive chronic disease management such as diabetes and COPD. The healthcare team can modify the patient’s treatment in real-time as the patient’s data continues to change.
We have seen the efforts of the various large health care systems accompanied by health technology startups that have leveraged the Internet of Medical Things (IoMT) to improve patient care, maximize efficiency, and improve access to reliable medical services.
The Internet of Medical Things (IoMT) has completely changed healthcare; it is no longer imaginary. Advanced AI diagnostics, remote patient care, and cloud-based devices are improving care, and closing gaps. IoMT will continue to become more pronounced and reliable with potentially less variation in terms of care.
As we look to 2030, the greatest opportunities will emerge from collaboration between healthcare providers, technology innovators, and policymakers. It will require building secure infrastructure, ethical and interoperable approaches, and expert medical softwares, to scale IoMT adoption worldwide.
International healthcare is on the verge of using the technologies that will shape the future of global healthcare. The world is becoming increasingly connected, which is a leap forward and the healthcare sector is leading the way.